Persistent response to combination therapy of pemigatinib and chemotherapy in a child of combined hepatocellular-cholangiocarcinoma with FGFR2 fusion

Press/Media

Period	Dec 6 2024

Media coverage

Title	Persistent response to combination therapy of pemigatinib and chemotherapy in a child of combined hepatocellular-cholangiocarcinoma with FGFR2 fusion
Media name/outlet	MOLECULAR CANCER
Country/Territory	United Kingdom
Date	12/6/24
URL	ct.moreover.com/?a=55482493222&p=1gw&v=1&x=Wi9hm9_sfWk9ceNMwrTw6g
Persons	Y. Lynn Wang